0000899243-19-017661.txt : 20190620
0000899243-19-017661.hdr.sgml : 20190620
20190620163424
ACCESSION NUMBER: 0000899243-19-017661
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190618
FILED AS OF DATE: 20190620
DATE AS OF CHANGE: 20190620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BREITMEYER JAMES B
CENTRAL INDEX KEY: 0001244823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 19908909
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-18
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001244823
BREITMEYER JAMES B
C/O ONCTERNAL THERAPEUTICS, INC.
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
President, CEO
Stock Options
0.81
2019-06-18
4
A
0
42196
0.00
A
2028-11-14
Common Stock
42196
42196
D
On November 14, 2018, the reporting person was granted an award of stock options that vest upon the achievement of certain pre-established strategic milestones. On June 18, 2019, the Compensation Committee of the Issuer's board of directors determined that one such strategic milestone had been achieved, resulting in the vesting of options to purchase 42,196 shares of the Issuer's common stock.
/s/ Hazel M. Aker, Attorney-in-fact
2019-06-20